PhenoVista

Biotechnology Research • San Diego, California, United States • 11-20 Employees

Company overview

Headquarters	6195 Cornerstone Ct E, Suite 114, San Diego, California 92121, US
Phone number	+18584659175
Website	phenovista.com
NAICS	541714
SIC	873
Keywords	Assay Development, Drug Discovery, Animal Health, Contract Research, Fluorescence Microscopy, High Content Screening, Immuno-Oncology, Neurobiology, Fibrosis, Cell Based Assays, Preclinical Services, Phenotypic Screening, Cell Models, In Vitro Assays, Cell & Gene Therapy, Cell Health, Cell Painting, 2D & 3D Assays
Founded	2014
Employees	11-20
Socials

Key Contacts at PhenoVista

James Evans

Ceo

Marshall Peterman

Associate Director Of Scientific Operations

Christopher Koehler

Director Of Scientific Operations

Erika Martin

Director Of Laboratory Operations

PhenoVista Email Formats

PhenoVista uses 2 email formats. The most common is {first initial} (e.g., j@phenovista.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}	j@phenovista.com	66.7%
{first name}	john@phenovista.com	33.3%

About PhenoVista

Founded in 2014, PhenoVista is a San Diego-based CRO specializing in modern human, cell-based in vitro assay development and analysis. Internationally recognized for developing and implementing both fully bespoke projects and pre-validated Ready-2-Go assay services, this award-winning research partner leverages high-content imaging to enable life scientists to accelerate their discovery of novel therapeutics and improve global health. Our areas of expertise include: - 3D Assay Development for a Variety of Cell Types and Models - Human iPS-derived Neuronal Health (Outgrowth, Autophagy, Synapse Formation, Mitochondrial Function) - Mitochondrial Structure and Function - Uptake and Subcellular Localization of Therapeutic Antibodies - Differentiation of Human Primary Cells - Metabolic Function and Disorders - Immuno-oncology Screens For more information about our assay services, contact us at https://phenovista.com/contact-us Connect with us on Facebook: http://www.facebook.com/PhenoVista-Biosciences-1565884820345796 Twitter: http://twitter.com/phenovista Instagram: http://www.instagram.com/phenovista/ Youtube: https://www.youtube.com/channel/UCa_J3Va5CNjFSH5SgYOTjyQ/discussion

PhenoVista revenue & valuation

Annual revenue	$4,111,111
Revenue per employee	$257,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$13,200,000
Total funding	$6,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

PhenoVista has 7 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore PhenoVista's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-01-13	19	$3,000,000
2023-01-13	1	$3,000,000

Funding Insights

$6,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

PhenoVista Tech Stack

Discover the technologies and tools that power PhenoVista's digital infrastructure, from frameworks to analytics platforms.

HubSpot Cookie Policy Banner

Cookie compliance

Cloudflare Bot Management

Security

HubSpot CMS Hub

CMS

Goober

JavaScript libraries

Swiper

JavaScript libraries

Google Maps

Maps

Envoy

Reverse proxies

Cloudflare

CDN

HubSpot Analytics

Analytics

HTTP/3

Miscellaneous

HSTS

Security

Amazon S3

CDN

Frequently asked questions

PhenoVista is located in San Diego, California, US.

You can reach PhenoVista at +18584659175.

PhenoVista was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

PhenoVista has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

PhenoVista has raised a total of $6,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.